Elizabeth M. Nielson, PhD, CASAC, is a psychologist at the Psychedelic Education and Continuing Care Program at The Center for Optimal Living where she specializes in individual and group psychedelic harm reduction and integration psychotherapy. Dr. Nielson received her PhD in Clinical Psychology from Walden University and completed an NIH-funded post-doctoral fellowship at NYU. Dr. Nielson is presently a therapist on the phase 2 trials of psilocybin-assisted treatment of alcohol dependence and of MDMA-assisted treatment of PTSD at NYU School of Medicine. Dr. Nielson’s own program of research includes qualitative studies of patient experiences in psilocybin research trials, psychedelic therapists’ experiences and methods, and the historical use of LSD as a training experience for therapists.
Revisiting Spring Grove’s LSD Training Experience Program
Between 1969 and 1974 researchers at the Spring Grove Research Center of the Maryland State Psychiatric Institute provided over 100 mental health professionals up to three doses of LSD as a training experience for work in psychedelic research, as psychedelic therapists, and other clinical work. Follow up data, including questionnaires, standardized rating scales, and written narratives, were collected but never systematically analyzed and published. Almost 50 years later no research group has recommenced the provision of a classic hallucinogen as a training experience in the US. This presentation reviews the history of the Spring Grove project and presents data from systematic analysis the study’s archives with an eye on the relevance to today’s psychedelic therapist training programs.
Pre-conference workshop – Psychedelic Integration
With Drs. Ingmar Gorman, & Elizabeth Nielson
1-Day Pre-Conference Workshop of Beyond Psychedelics 2018 June 19, Prague
What is psychedelic harm reduction and integration and how can they occur in a clinical setting? This day long training offered by psychologists Ingmar Gorman PhD and Elizabeth Nielson PhD is designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice. We will focus on translating research findings into clinical practice including working with patients who are considering using psychedelics, actually using psychedelics, or have used them. This program includes discussion of assessment and integration techniques, resources, and legal and ethical issues.